CD-10 immunostaining differentiates superficial basal cell carcinoma from cutaneous squamous cell carcinoma.

@article{Wagoner2007CD10ID,
  title={CD-10 immunostaining differentiates superficial basal cell carcinoma from cutaneous squamous cell carcinoma.},
  author={Justin Wagoner and Connie A Keehn and Michael B. Morgan},
  journal={The American Journal of dermatopathology},
  year={2007},
  volume={29 6},
  pages={555-8}
}
Basal cell carcinoma and squamous cell carcinoma are common entities in clinical practice. Their distinction can be difficult clinically as well as histologically. CD10 or common acute lymphoblastic leukemia antigen (CALLA) is a metallomembrane endopeptidase expressed on a variety of normal and neoplastic cells. We sought to determine if the CD10 immunostain could have diagnostic utility in distinguishing between early superficial basal cell carcinoma (BCC) and squamous cell carcinoma (SCC… CONTINUE READING